# A Pharmacokinetics Study of Radioactive-Labeled GDC-0973 in Healthy Male Volunteers

> **NCT01711762** · PHASE1 · COMPLETED · sponsor: **Genentech, Inc.** · enrollment: 6 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** GDC-0973

## Key facts

- **NCT ID:** NCT01711762
- **Lead sponsor:** Genentech, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2012-09
- **Final completion:** 2012-09
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2016-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01711762

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01711762, "A Pharmacokinetics Study of Radioactive-Labeled GDC-0973 in Healthy Male Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01711762. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*